1.61
                                            전일 마감가:
              $1.76
            열려 있는:
              $1.8
            하루 거래량:
                3.69M
            Relative Volume:
              0.53
            시가총액:
                $193.43M
            수익:
              -
            순이익/손실:
              $-225.14M
            주가수익비율:
              -0.8214
            EPS:
                -1.96
            순현금흐름:
                $-192.27M
            1주 성능:
              -25.12%
            1개월 성능:
              +38.79%
            6개월 성능:
                +156.21%
            1년 성능:
              +76.23%
            Invivyd Inc Stock (IVVD) Company Profile
명칭
                  
                      Invivyd Inc
                    
                전화
                  
                      (781) 819-0080
                    
                주소
                  
                      1601 TRAPELO ROAD, WALTHAM
                    
                IVVD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                IVVD
                            
                             
                        Invivyd Inc 
                           | 
                    1.61 | 377.36M | 0 | -225.14M | -192.27M | -1.96 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-10-06 | 개시 | Cantor Fitzgerald | Overweight | 
| 2024-04-05 | 업그레이드 | Guggenheim | Neutral → Buy | 
| 2024-03-26 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight | 
| 2023-12-19 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight | 
| 2023-05-01 | 개시 | H.C. Wainwright | Buy | 
Invivyd Inc 주식(IVVD)의 최신 뉴스
Is Invivyd Inc. stock vulnerable to regulatory risksEarnings Beat & Technical Pattern Alert System - newser.com
HC Wainwright & Co. Maintains Invivyd (IVVD) Buy Recommendation - Nasdaq
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025 - The Manila Times
H.C. Wainwright doubles Invivyd stock price target to $10 on COVID-19 program - Investing.com
Custom strategy builders for tracking Invivyd Inc.Weekly Stock Recap & Stepwise Trade Signal Guides - newser.com
Can Invivyd Inc. stock deliver consistent earnings growthBull Run & Real-Time Volume Spike Alerts - newser.com
Invivyd Inc. stock momentum explained2025 Technical Overview & Safe Entry Zone Identification - newser.com
Using economic indicators to assess Invivyd Inc. potentialMarket Growth Report & Reliable Price Action Trade Plans - newser.com
What is the fair value of Invivyd Inc. stock now2025 Market Overview & Comprehensive Market Scan Insights - newser.com
Invivyd Inc. stock volume spike explainedPortfolio Risk Summary & Real-Time Market Trend Scan - newser.com
Will Invivyd Inc. stock gain from strong economyGlobal Markets & Detailed Earnings Play Alerts - newser.com
How institutional buying supports Invivyd Inc. stock2025 Top Decliners & Growth Focused Stock Reports - newser.com
Backtesting results for Invivyd Inc. trading strategiesMarket Activity Report & Free Daily Entry Point Trade Alerts - newser.com
Real time pattern detection on Invivyd Inc. stockJuly 2025 News Drivers & Short-Term High Return Strategies - newser.com
Visual trend scoring systems applied to Invivyd Inc.July 2025 Update & Consistent Profit Alerts - newser.com
Why analysts upgrade Invivyd Inc. stockJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Why Invivyd Inc. stock is popular among millennialsStock Surge & Breakout Confirmation Trade Signals - newser.com
What drives Invivyd Inc stock priceHead and Shoulders Patterns & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in
Invivyd (NASDAQ:IVVD) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Invivyd, Inc. (NASDAQ:IVVD) Short Interest Up 156.9% in October - MarketBeat
Invivyd price target raised to $10 from $5 at H.C. Wainwright - MSN
H.C. Wainwright Maintains Invivyd(IVVD.US) With Buy Rating, Raises Target Price to $10 - 富途牛牛
Invivyd (IVVD) Analyst Rating: HC Wainwright Raises Price Target to $10 | IVVD Stock News - GuruFocus
Invivyd Highlights Antibody Development in New Presentation - MSN
Invivyd (IVVD) Price Target Increased by 88.89% to 5.78 - MSN
Candlestick signals on Invivyd Inc. stock todayOil Prices & High Yield Stock Recommendations - newser.com
Invivyd, Inc. (NASDAQ:IVVD) Given Average Rating of "Hold" by Brokerages - MarketBeat
[8-K] Invivyd, Inc. Reports Material Event | IVVD SEC FilingForm 8-K - Stock Titan
Invivyd, Inc. (IVVD) Discusses REVOLUTION Clinical Program and Development of VYD2311 Antibody for COVID PreventionSlideshow (NASDAQ:IVVD) 2025-10-30 - Seeking Alpha
Invivyd Inc (IVVD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
                자본화:
                 
                  | 
                볼륨(24시간):